Kirk Taylor Announces Postdoctoral Research Opportunity on Megakaryocyte and Platelet Communication at University of Reading
Kirk Taylor, Lecturer in Biomedical Sciences in the University of Reading, shared an insightful post on LinkedIn:
“Pleased to share that we are looking to recruit a postdoc to join the Reading Platelet Group.
This is an exciting project that will explore how megakaryocytes and platelets communicate using advanced microscopy and flow cytometry approaches.
The project will dissect and characterise intercellular communication pathways to build a model of how megakaryocytes and platelets interact. The experimental design will increase the complexity of interactions and the role of control mechanisms in 2D, 3D, and 4D. Using established in vivo approaches, the post holder will design and conduct assays to model thrombus formation under physiologically relevant conditions.
The postholder is expected to be a central link in the communication of staff involved in the project. In particular, this includes collaboration with a second PDRA employed by the project responsible for theoretical and computational developments. Strong communication skills and an ability to work in a multidisciplinary environment are hence essential.”
Apply here:
Stay updated with Hemostasis Today.
-
Feb 16, 2026, 06:21C. Michael Gibson: Favorable Safety Outcomes With Asundexian
-
Feb 16, 2026, 06:18Jecko Thachil: What Do Clinicians Mean by “Coagulopathy”?
-
Feb 16, 2026, 06:04Inside 2026 Highlights of ASH in the Mediterranean, Middle East, and North Africa with Dr. Heghine Khachatryan
-
Feb 15, 2026, 10:56Don’t Miss PNH: Clinical Practice From ISTH – Medscape
-
Feb 15, 2026, 10:52Awareness and Research on Factor V Deficiency Are Critical – EHC
-
Feb 15, 2026, 10:43Peter Zdziarski: Protecting Patient Data in the Rare Disease Community
-
Feb 15, 2026, 10:31Michiel Voet: The Price Tag of a Whole Blood Strategy
-
Feb 15, 2026, 10:26Sifat Jubaira: K₂-EDTA vs K₃-EDTA – Same Anticoagulant, Very Different Accuracy
-
Feb 15, 2026, 09:29Gevorg Tamamyan: Childhood Cancer is Curable. Inequity Is Not